(Q46495621)

22 December 2017

title

Evidence that insulin can directly inhibit hepatic glucose production (English)

1 reference

22 December 2017

4

G M Reaven

1 reference

22 December 2017

P Maheux

1

1 reference

22 December 2017

Y D Chen

series ordinal

2

1 reference

22 December 2017

K S Polonsky

series ordinal

3

1 reference

22 December 2017

publication date

1 November 1997

1 reference

22 December 2017

published in

Diabetologia

1 reference

22 December 2017

volume

40

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

1300-1306

1 reference

22 December 2017

Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Immunoassay of insulin with insulin-antibody precipitate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Characterization of seven C-peptide antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Effect of time on measurement of hepatic glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Dynamics of Tolbutamide, Glucose, and Insulin Interrelationships Following Varying Doses of Intravenous Tolbutamide in Normal Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Effect of difference in glucose infusion rate on quantification of hepatic glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Thoracic duct lymph. Relative contribution from splanchnic and muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS001250050824

Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function

21 January 2018

1 reference

12 December 2020

INHIBITION BY INSULIN OF HEPATIC GLUCOSE PRODUCTION IN THE NORMAL DOG

1 reference

12 December 2020

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

12 December 2020

Dose-response characteristics for effects of insulin on production and utilization of glucose in man

1 reference

12 December 2020

A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion

1 reference

12 December 2020

Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose

1 reference

12 December 2020

Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects

1 reference

12 December 2020

Differential Sensitivity of Glycogenolysis and Gluconeogenesis to Insulin Infusions in Dogs

1 reference

12 December 2020

Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects

1 reference

12 December 2020

Peripheral effects of insulin dominate suppression of fasting hepatic glucose production

1 reference

12 December 2020

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

12 December 2020

Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo

1 reference

12 December 2020

ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE

1 reference

12 December 2020

Identifiers

DOI

10.1007/S001250050824

1 reference

22 December 2017

1 reference

22 December 2017